J. Goldman & Co’s Alkermes ALKS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
– Sell
-21,425
Closed -$613K – 453
2025
Q2
$613K Sell
21,425
-88,626
-81% -$2.64M 0.01% 371
2025
Q1
$3.63M Buy
+110,051
New +$3.59M 0.09% 240
2023
Q4
– Sell
-52,836
Closed -$1.48M – 335
2023
Q3
$1.48M Buy
+52,836
New +$1.55M 0.05% 221
2022
Q3
– Sell
-173,124
Closed -$5.16M – 383
2022
Q2
$5.16M Buy
+173,124
New +$4.97M 0.25% 101
2021
Q2
– Sell
-60,074
Closed -$1.12M – 398
2021
Q1
$1.12M Buy
+60,074
New +$1.23M 0.04% 296

Other funds holding ALKS

J. Goldman & Co's ALKS Position: Q3 2025 in Review

J. Goldman & Co sold out of Alkermes (ALKS) in Q3 2025, closing a stake of 21,425 shares — an estimated $613K sold.

J. Goldman & Co first reported a position in ALKS in Q1 2021 and held it in 5 quarters. The position peaked at $5.16M in Q2 2022. 358 funds tracked by Wall St. Rank hold ALKS as of Q3 2025.

  • J. Goldman & Co reported no remaining Alkermes position as of Q3 2025 after selling out during the quarter.
  • J. Goldman & Co sold 21,425 Alkermes shares in Q3 2025, an estimated $613K.
  • J. Goldman & Co first reported a position in Alkermes in Q1 2021 and held it in 5 quarters.
  • J. Goldman & Co's Alkermes position peaked at $5.16M in Q2 2022.
  • 358 funds tracked by Wall St. Rank held Alkermes as of Q3 2025.

Based on J. Goldman & Co's 13F filing for Q3 2025, filed 14 Nov 2025.